15:14:33United States

Immunic, Inc. (IMUX)

NASDAQ

Key stats Fiscal year 2025

Income statement

Net income
-97,172,000
Operating income
-103,228,000
Earnings per share
-0.62

Balance sheet

Total assets
24,052,000
Total liabilities
30,725,000
Shareholders' equity
-6,673,000
Cash and equivalents
15,483,000
Current ratio
0.75

Cash flow and ratios

Operating cash flow
-85,806,000
Free cash flow
-85,967,000

Fiscal year end: · Source: SEC EDGAR

Immunic, Inc. trades on NASDAQ under the ticker symbol IMUX. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis